Work

Historical gold standard for time-to-progression (TTP) and progression-free survival (PFS) from relapsed/refractory neuroblastoma modern era (2002-2014) patients.

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.15_suppl.10034

Authors: Wendy B. London, Rochelle Bagatell, Brenda Weigel, Elizabeth Fox, Collin Van Ryn, Arlene Naranjo, Mark D. Krailo, Charlotte H. Ahern, Julie R. Park

Institutions: Boston Children's Hospital, Dana-Farber Cancer Institute, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Children's Hospital of Philadelphia, University of Minnesota, University of Florida, Children's Oncology Group, Baylor College of Medicine, Seattle Children's Hospital

Language: English

Topic: Neuroblastoma Research and Treatments

Subfield: Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2594761541

Cites:

Cited by: 4

Related to: 10